posts daily archives

4월 6, 2018

CRISPR-Cas9 commercial research tool technology acquired from Broad Institute will be used to build preclinical model animals and target treatment function analysis to further gene treatment research and development Macrogen, Inc. (CEO Ji-young Moon, www.macrogen.com), a precision medicine biotechnology company, announced on April 5 that it …

Continue reading